Increasing Naloxone Access for Persons Who Use Opioids

Sponsor
University of Alabama at Birmingham (Other)
Overall Status
Completed
CT.gov ID
NCT04303000
Collaborator
(none)
304
4
2
14.1
76
5.4

Study Details

Study Description

Brief Summary

Deaths relating to opioid overdose have rapidly increased over the past two decades. Due to the serious public health concern of the opioid epidemic, federal agencies recommend employing various harm reduction interventions. The implementation of Opioid Overdose Education and Naloxone Distribution (OEND) programs is effective in reducing opioid overdose mortality, yet these programs do not reach many high-risk individuals. Traditionally, OEND program venues are found in large, urban medical centers, drug treatment facilities, and needle exchange programs. Identifying unreached, high-risk individuals and providing training and naloxone kits through online recruitment could significantly expand access to this life-saving intervention. The primary goal of the current proposed project is to examine the acceptability and feasibility of online recruitment, online opioid overdose and naloxone administration education, and postal distribution of naloxone kits.

Condition or Disease Intervention/Treatment Phase
  • Drug: Opioid Overdose Education with Naloxone Distribution
  • Drug: Opioid Overdose Education
Phase 4

Detailed Description

Drug overdose is the leading cause of accidental death in the United States, with over 65% of drug related fatalities resulting from the use of opioids. The continually increasing rates of opioid overdose deaths in the last two decades have led to the declaration of an opioid epidemic. Over a brief 15-year period, from 1999-2014, drug overdose related deaths tripled and rates have continued to sharply escalate since then. Federal agencies have responded to this crisis with various recommendations including enhancing harm reduction approaches such as naloxone distribution. Naloxone is an opioid antagonist that can be used to reverse opioid overdose. Though it is typically administered in Emergency Departments, laypersons have recently been successfully trained through Opioid Overdose Education and Naloxone Distribution (OEND) programs to recognize signs of opioid overdose and perform timely administration of naloxone in homes and community settings while awaiting medical services. Several studies have demonstrated that OEND programs effectively reduce opioid overdose mortality and are safe and cost-effective. However, OEND programs are typically implemented in urban areas as part of large medical center research programs, needle exchanges, or drug treatment programs. Individuals living in areas without these programs or services lack access to critical and life-saving OEND. The current proposal will examine the acceptability and feasibility of online recruitment, online opioid overdose education, and postal distribution of naloxone kits (N=80). Opioid users at risk for overdose will be recruited online through Craigslist. If eligible, participants will complete an opioid use questionnaire and will indicate if they are interested in receiving opioid overdose and naloxone administration training. If interested, they will complete pre- and post-intervention knowledge questionnaires, engage in audiovisual training, and half will be randomized to receive a naloxone kit in the mail while the other half will be given information on where they can receive a naloxone kit. All participants will complete remote follow-up assessments at 1, 2, and 3 months post study to evaluate naloxone kit use and outcomes. This study will evaluate a novel approach to providing OEND to individuals with otherwise limited access to this type of intervention. Successful implementation of remote OEND through this project would support future employment of similar remote programs to expand this critical harm reduction strategy to high-risk individuals in areas lacking traditional OEND programs.

Study Design

Study Type:
Interventional
Actual Enrollment :
304 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Increasing Naloxone Access for Persons Who Use Opioids: An Online Recruitment and Training Approach to Opioid Overdose Education and Naloxone Distribution
Actual Study Start Date :
Nov 11, 2020
Actual Primary Completion Date :
Oct 3, 2021
Actual Study Completion Date :
Jan 13, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Opioid Overdose Education and Naloxone Distribution

Participants will engage in online audiovisual training focused on recognizing the signs of an opioid overdose and the procedural steps for how to administer naloxone. Participants randomized to this arm will be provided with a naloxone nasal spray kit (4mg).

Drug: Opioid Overdose Education with Naloxone Distribution
Online audiovisual training focused on recognizing the signs of an opioid overdose and administering naloxone. Participants are provided with a naloxone kit.
Other Names:
  • Narcan
  • Active Comparator: Opioid Overdose Education

    Participants will engage in online audiovisual training focused on recognizing the signs of an opioid overdose and the procedural steps for how to administer naloxone. Participants randomized to this arm will receive information about pharmacies in their area where they can purchase a naloxone kit.

    Drug: Opioid Overdose Education
    Online audiovisual training focused on recognizing the signs of an opioid overdose and administering naloxone. Participants are provided with information on where they can obtain a naloxone kit.
    Other Names:
  • Narcan
  • Outcome Measures

    Primary Outcome Measures

    1. Feasibility of Online Opioid Overdose Education and Remote Naloxone Distribution [12 months]

      Feasibility of online opioid overdose education and remote naloxone distribution as indicated by recruitment of 80 participants in 12 months, increase in opioid knowledge post-training, and 80% completion of assessment measures.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 18 years of age or older

    • Current or past six months illicit use of opioids

    • Electronic device access for online survey completion

    • Willing to provide email address to receive survey link and compensation

    • Able to read and speak English

    • Willing to provide their contact information and that of two friends/family members

    • Permanent address for mailing of naloxone kit

    • Does not currently have a naloxone kit in possession

    Exclusion Criteria:
    • Contraindication for naloxone (known severe allergic reaction)

    • Cognitive impairment or unstable psychiatric condition that interferes with the informed consent process

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Craigslist Anniston Alabama United States 36201
    2 Craigslist Gadsden Alabama United States 35901
    3 Craigslist Mobile Alabama United States 36695
    4 Craigslist Montgomery Alabama United States 36117

    Sponsors and Collaborators

    • University of Alabama at Birmingham

    Investigators

    • Principal Investigator: Michelle Sisson, MA, University of Alabama at Birmingham

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Michelle Sisson, M.A., Doctoral Student, University of Alabama at Birmingham
    ClinicalTrials.gov Identifier:
    NCT04303000
    Other Study ID Numbers:
    • IRB-300004762
    First Posted:
    Mar 10, 2020
    Last Update Posted:
    May 16, 2022
    Last Verified:
    May 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    Yes
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    Yes
    Keywords provided by Michelle Sisson, M.A., Doctoral Student, University of Alabama at Birmingham
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 16, 2022